"Occult Blood" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
| Descriptor ID |
D009780
|
| MeSH Number(s) |
E01.370.225.925 E05.200.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Occult Blood".
Below are MeSH descriptors whose meaning is more specific than "Occult Blood".
This graph shows the total number of publications written about "Occult Blood" by people in this website by year, and whether "Occult Blood" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2016 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Occult Blood" by people in Profiles.
-
Wender RC. Should Routine Screening for Colorectal Cancer Start at 45 Years of Age? Yes: Lowering the Starting Age Is a Settled Issue. Am Fam Physician. 2022 02 01; 105(2):120-121.
-
Nash DB, Fabius RJ, Skoufalos A. Preventing Colorectal Cancer: Pathway to Achieving an 80% Screening Goal in the United States: Overview and Proceedings of a Population Health Advisory Board. Popul Health Manag. 2021 04; 24(2):286-295.
-
Myers RE. Low rates of diagnostic colonoscopy in Federally Qualified Health Centers: A persistent problem that must be addressed to achieve the promise of colorectal cancer screening. Cancer. 2019 12 01; 125(23):4134-4135.
-
Ritvo P, Myers RE, Serenity M, Gupta S, Inadomi JM, Green BB, Jerant A, Tinmouth J, Paszat L, Pirbaglou M, Rabeneck L. Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials. Prev Med. 2017 Aug; 101:229-234.
-
Lieberman D, Ladabaum U, Cruz-Correa M, Ginsburg C, Inadomi JM, Kim LS, Giardiello FM, Wender RC. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review. JAMA. 2016 Nov 22; 316(20):2135-2145.
-
Myers RE, Sifri R, Daskalakis C, DiCarlo M, Geethakumari PR, Cocroft J, Minnick C, Brisbon N, Vernon SW. Increasing colon cancer screening in primary care among African Americans. J Natl Cancer Inst. 2014 Dec; 106(12).
-
Daskalakis C, Vernon SW, Sifri R, DiCarlo M, Cocroft J, Sendecki JA, Myers RE. The effects of test preference, test access, and navigation on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1521-8.
-
Sarfaty M, Doroshenk M, Hotz J, Brooks D, Hayashi S, Davis TC, Joseph D, Stevens D, Weaver DL, Potter MB, Wender R. Strategies for expanding colorectal cancer screening at community health centers. CA Cancer J Clin. 2013 Jul-Aug; 63(4):221-31.
-
Sarfaty M, Myers RE, Harris DM, Borsky AE, Sifri R, Cocroft J, Stello B, Johnson M. Variation in colorectal cancer screening steps in primary care: basis for practice improvement. Am J Med Qual. 2012 Nov-Dec; 27(6):458-66.
-
Tinmouth J, Ritvo P, McGregor SE, Claus D, Pasut G, Myers RE, Guglietti C, Paszat LF, Hilsden RJ, Rabeneck L. A qualitative evaluation of strategies to increase colorectal cancer screening uptake. Can Fam Physician. 2011 Jan; 57(1):e7-15.